Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

Abbott Labs to acquire Madison’s Exact Sciences in $23 billion deal

The company will maintain its presence in Madison and CEO Kevin Conroy will remain “in an advisory role,” said Zach Brandon, president of the Greater Madison Chamber of Commerce.

Abbott Labs to acquire Madison’s Exact Sciences in $23 billion deal

The company will maintain its presence in Madison and CEO Kevin Conroy will remain “in an advisory role,” said Zach Brandon, president of the Greater Madison Chamber of Commerce.

Why Exact Sciences Stock Surged Today

Key PointsAbbott made a takeover offer for Exact Sciences.The two companies want to team up to combat cancer.10 stocks we like better than Exact Sciences › Shares of Exact Sciences (NASDAQ: EXAS) climbed on Thursday after the medical diagnostics specialist agreed to be acquired by Abbott (NYSE: ABT) for $21 billion. As of 2:30 p.m. EST, Exact Sciences' stock price was up more than 17%.Where to invest $1,000 right now? Our analyst team just revea…

Abbott Laboratories to acquire Madison, Wis.-based company specializing in advanced cancer screening, diagnostics

Abbott Laboratories, headquartered in north suburban Abbott Park, will acquire Madison, Wisconsin-based Exact Sciences, the companies announced in a news release Thursday, raising Abbott's total diagnostic sales to over $12 billion annually.

Madison's Exact Sciences will be acquired by Abbott pharmaceutical company

Abbott Laboratories is buying Madison-based biotechnology company Exact Sciences in a $23 billion deal, the companies announced Thursday. The post Madison’s Exact Sciences will be acquired by Abbott pharmaceutical company appeared first on WPR.

Abbott to buy Madison-based Exact Sciences in deal valued at up to $23 billion

The deal will add the cancer test Cologuard to Abbott's portfolio.